secwatch.observer — SEC 8-K summary
======================================

Issuer:     DiaMedica Therapeutics Inc. (DMAC)
CIK:        0001401040
Form:       8-K
Filed at:   2022-02-11T23:59:59+00:00
Accession:  0001437749-22-003142
Event type: other
Sentiment:  neutral
Materiality: 0.05
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

DiaMedica sets May 18, 2022 for annual meeting; shareholder proposal deadline March 4, 2022
--------------------------------------------------------------------------------

- Annual general meeting scheduled for May 18, 2022; date changed by more than 30 days from last year.
- Proxy materials expected to be printed March 30 and sent to shareholders around April 5, 2022.
- Shareholder proposals for inclusion in proxy must be received by March 4, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1401040/000143774922003142/0001437749-22-003142-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1401040/000143774922003142/dmtp20220211_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-22-003142

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer